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Introduction
In 1966, Drudge and Lyons [1] were first to describe a
modern equine anthelmintic program based on
suppressive treatments. The first benzimidazole type
drugs had recently entered the market, and with these
modern safe and broad spectrum drugs, a whole new
approach could be taken. Drudge and Lyons used the best
scientific evidence available at the time to suggest a
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Abstract
Given the increasing levels of anthelmintic resistance in equine parasites, parasitologists now
recommend traditional treatment approaches to be abandoned and replaced by more sustainable
strategies. It is of crucial importance to facilitate veterinary involvement to ensure that treatment
decisions are based on parasitic knowledge. Despite recommendations given for the past two
decades, strategies based on the selective therapy principle have not yet been implemented on a
larger scale in equine establishments. In contrast, treatment regimens appear to be derived from
recommendations originally given in 1966.The province of Quebec in Canada, and an increasing
number of European countries, have implemented prescription-only restrictions on anthelmintic
drugs. Denmark introduced this legislation ten years ago, and some evidence has been generated
describing potential consequences. It is without dispute that Danish veterinarians are now deeply
involved with parasite management in equine establishments. However, little is known about the
impact on levels of anthelmintic resistance and the risk of parasitic disease under these
circumstances. In addition, the legislation makes huge demands on diagnosis and parasite
surveillance. No data have been published evaluating fecal egg count techniques and larval culture
methods as clinical diagnostic tools,and very little is known about potential correlations with actual
worm burdens.This article provides a general review of anthelmintic strategies currently used in
equine establishments and outlines the recommendations now given for parasite control.
Preliminary experience with prescription-only restrictions in Denmark is presented and current
research needs to further evaluate this approach are discussed.
Open Accesstreatment protocol involving treatment of all horses every
other month year-round. This protocol has since then
been denoted the interval dose regimen.
Drudge and Lyons identified Strongylus vulgaris as the
primary target of the program given its high pathogenic
potential, and they used knowledge about life-cycles and
egg reappearance periods to determine treatment intervals.
In 1966, anthelmintic resistance in equine parasites was
already recognized on a single-case basis [2-4] but was not
considered a potential generalized problem in horse
establishments. It was therefore considered a solid
approach to treat all horses with fixed year-round treat-
ments to suppress egg shedding and thereby reduce
parasite transmission to a minimum. Drudge and Lyons
also suggested rotating between drug classes to ensure that
all parasite groups were targeted in the treatment regimen.
With the advent of new drug classes such as pyrimidines
(pyrantel) in the 1970s and avermectin/milbemycins
(ivermectin and moxidectin) in the 1980s, more anthel-
mintic classes were now available. In the sheep industry,
rotation between drugs was now recommended as a
strategy to counteract development of anthelmintic
resistance [5], and this principle was quickly adopted in
the horse industry as well. The drugs available were now
all broad spectrum, so the purpose of the rotation was no
longer to ensure a targeting of all parasite groups, but
entirely to prevent anthelmintic resistance. However, no
experimental evidence suggests that this is feasible, and
one study suggests the opposite [6].
Presently, cyathostomin populations have been reported
widely resistant to benzimidazole drugs and increasingly
resistant to pyrantel formulations [7,8]. In addition,
Parascaris equorum isolates have been reported resistant to
ivermectin [9-16] and moxidectin [9,13,15]. One study
confirmed a purportedly resistant Canadian isolate by
experimentally infecting foals and subsequently
euthanizing them after blinded ivermectin treatments of
half the foals [17]. Most recently several studies have
reported that egg reappearance periods in cyathostomins
after ivermectin treatment have been shortened from
about eight weeks to about four weeks in the US [18],
Brazil [19] and Germany [12]. With a critical test study,
Lyons and coworkers recently illustrated that the shorter
egg reappearance in cyathostomins appear to be due to
immature stages in the intestinal lumen now surviving
treatments, which indicates ivermectin resistance on that
particular stage [20].
This clearly illustrates a need for a change in strategy.
Treating all horses with frequent intervals year-round is
considered the major reason for the current levels of
anthelmintic resistance. With the ready availability of
cheap and safe over-the-counter anthelmintic products,
the veterinarian is now rarely involved with parasite
control, and treatment decisions are now made without
considering the biology of the parasites.
Parasitologists have warned about this increasingly for the
past two decades, and several reports have advocated for
more veterinary involvement [7,21,22]. Today, there is
general agreement that anthelmintic strategies should
maintain adequate levels of parasite refugia through a less
intensive anthelmintic program [7,8,23-25]. The most
consistently recommended strategy is selective therapy
(targeted treatments), which is based on a principle of
selecting individuals in the herd for treatment and leave
the rest untreated. The basis for this is the well-described
over-dispersion of parasites in hosts [26-28], where a
minority of animals harbours the majority of parasites.
With the trichostrongyle Haemonchus contortus, a highly
pathogenic blood-sucking abomasal nematode of rumi-
nants, this principle has been practised by evaluating
mucosal pallor as an indication of anaemia levels caused
by the parasites. This system known as FAMACHA® [29]
has proven highly applicable for small ruminants in areas
where  Haemonchus contortus predominates [30-33], but
less useful in an area with lower prevalence of this parasite
[34]. Other proposed methods for selecting “wormy”
individuals are based on body-condition scoring or
weighing animals on regular bases, and treating those with
weight-loss or less satisfactory weight-gain [24].
With horses, recommendations of selective therapy are
based on fecal analysis from all horses on the premises, and
treatment of those exceeding a predetermined cut-off value.
Pioneering scientists published preliminary studies already
in 1991 suggesting that a control strategy based on the
selective therapy principle was a valid approach [35,36].
Since then, other equine publications have followed up on
the principle and provided some evidence illustrating the
usefulness of this approach [37-39]. The rationale for this
treatment principle is that individual horses have a strong
tendency to consistently remain at the same level of egg
shedding over time [36,39,40]. Thus, a minority of horses
will consistently be shedding the majority of eggs in the
population, while a majority remains at very low or even
undetectable egg count levels. The choice of cut-off value
for treatment typically lies in the range of 0-500 eggs per
gram (EPG) with 200 EPG being the most often used
[48,60]. However, no studies have been performed
evaluating these choices from a health risk assessment or
parasite control point of view, and such studies are needed
to further develop and evaluate this approach.
Anthelmintic strategies currently used
Several questionnaire surveys have illustrated parasite
control strategies in the past decade and these are
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suggest a general trend of relatively frequent treatments
without considering the size and composition of the
worm burden. The majority of these surveys have no
mention of usage of fecal egg counts, and only a couple of
surveys report that less than 1% used these as a means of
surveillance [46,47].
In summary, the large body of evidence indicates that the
interval dose regimen is still the basic principle used in
equine establishments in countries representing three
different continents. Thus it is fair to assume that the
above-mentioned recommendations of reducing the
treatment intensity and basing treatments on parasite
surveillance instead of treating prophylactically have not
yet reached the equine industry, and the principle of
selective therapy appears to be not used at all. Instead a
treatment regimen, which was proposed in 1966 is
considered the standard treatment method. This clearly
illustrates a fundamental problem; scientific information
generated by parasitologists does not appear to get
disseminated to the horse industry. Reasons for this are
probably several, but it has been identified as a general
problem that veterinarians are no longer involved in the
parasite control programs.
Prescription-only restrictions
One way to ensure veterinary involvement is to make
drugs available on prescription-only premises. In Europe,
the trend goes towards such conditions in several
countries, because of a recent European Union (EU)
directive. This directive is very complex but the underlying
principle is to prevent over usage of drugs in the livestock
industry. Thus, veterinary drugs can only be applied by
trained personnel, and only after a condition being
diagnosed by a veterinarian. Technically, horses are
regarded as production animals like cattle and swine, and
the rules include anthelmintic drugs. As a result, over
recent years Sweden, the Netherlands and Finland have
implemented prescription-only restrictions on anthel-
mintic drugs, and more EU countries are likely to follow.
In Denmark, such restrictions were implemented already
10 years ago, and this country has thus generated valuable
experience with this legislation. In addition to this, the
province Quebec in Canada has had similar legislations
since the 1980s, which is exceptional in North America.
In Denmark, however, some information has been
gathered. In 1995, a questionnaire survey was performed
among Danish horse owners describing their approaches
for parasite control [22]. At that time, anthelmintic drugs
were still available over the counter, and the treatment
approaches employed were similar to those described in
other countries. On average, Danish horse owners treated
foals, young horses and adult horses 4.3, 4.0 and 3.7
times annually, respectively. Horse owners used 2.4
different drug types per year with only limited fecal egg
counts being performed.
In 1999, the prescription-only legislation came into effect
in Denmark. The increasing levels of anthelmintic resis-
tance in parasitic nematodes led Danish legislators to take
this step. The legislation applies to both large and small
animals, including horses, and the overall aim was to
encourage veterinary involvement to reduce anthelmintic
usage and development of drug resistance.
In 2004, a questionnaire survey was performed among
Danish equine veterinary practitioners [48]. The aim was to
describe how the prescription-only conditions had affected
veterinarians in their approach to parasite control. A
number of notable findings were made. Overall, equine
practitioners appeared to be largely involved with parasite
control. Ninetyseven % of the respondents were performing
fecal egg counts on a routine basis and 41% also performed
larval cultures for identifying large strongyle species. The
primary parasite management was performed within the
active grazing season with the majority of fecal sampling
and anthelmintic treatments being performed in the spring
and fall, while very little activity occurred in the winter
months. A majority of practices used the selective therapy
principle and cut-offs for treatment centered around 200
eggs per gram feces. Because of this an estimate of yearly
number of treatments per horse was not possible to achieve
due to the fact that it would depend on the actual fecal egg
count in each horse. Altogether, however, the survey
indicated that for adult horses most practitioners used a
two-samples-per-year approach, while younger horses
appeared to get treated on additional occasions.
Danish experiences
The clearly different treatment scenario in Denmark gives
rise to at least two questions; 1) Has the selection pressure
for anthelmintic resistance been reduced in Denmark,
and 2) can adequate parasite control be achieved under
the drug restrictions? Although more studies are definitely
needed to fully answer these questions, a few have been
performed over recent years, and some indication of the
answers can be found.
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Table 1 - Recent questionnaire surveys reporting the number of annual
anthelmintic treatments in equine establishments
Country Annual treatments References
United Kingdom 6 [41,42,43,44]
Ireland 8-12 [21]
South Africa 5-7 [45]
Sweden 3.2 [46]
USA 4 or more [47]Earlier studies performed in Denmark had indicated
pyrantel resistance [49], while signs of ivermectin resis-
tance in Parascaris equorum was documented in one horse
herd [11]. In 2008, we performed two surveys evaluating
anthelmintic resistance in Danish horse farms. One study
evaluated pyrantel embonate, and the other ivermectin.
The studies will be published in separate reports but the
main findings are summarized below.
Pyrantel efficacy
This study has been presented at the World Association for
the Advancement of Veterinary Parasitology (WAAVP)
Meeting in 2009 [50]. In brief, 64 horse farms with a total
of 1644 horses were investigated using the fecal egg count
reduction test (FECRT). Horses shedding at least 200
strongyle eggs per gram feces pretreatment were included in
the FECRT. Overall, mean farm efficacies ranged from 80%
to 100%, with only one farm having an efficacy lower than
80%. Fifty-six farms had efficacies above 90%, and nine
were in the range of 80-90%. Although none of the farms
were experiencing treatment failure, this study suggests that
pyrantel resistance is present in Denmark, despite the
legislation. However, selection for resistant parasite strains
may have occurred prior to 1999. Thus, in the study by
Craven et al. [49], slight indications of emerging pyrantel
resistance were found, and the drug restrictions may have
been introduced too late to effectively delay further
development of resistance. In addition, pyrantel embonate
paste was recently found to be routinely used by two thirds
of Danish equine practitioners [48].
Studies performed in countries surrounding Denmark
have suggested emerging pyrantel resistance as well. In
Sweden, pyrantel efficacies were found in the range of 95-
100%, but the high variability led to wide 95%
confidence limits on some farms, which raised suspicion
of developing resistance [51]. Similar findings were
recently made in Germany, where efficacy levels were 92-
100%, but confidence intervals very wide [12]. However,
these two studies used a McMaster technique with a detec-
tion limit of 50 eggs per gram (EPG), where low post
treatment egg counts will remain undetected. Thus, such
an egg count technique will largely overestimate drug
efficacy for horses with moderate egg counts. The Danish
2008 study used a modified McMaster technique with a
detection limit of 20 EPG, so efficacy levels cannot be
compared across these studies.
In summary, it remains unknown whether Danish drug
restrictions have affected pyrantel efficacy, and more
evidence is needed to make any solid conclusions.
Ivermectin efficacy
This study has been presented at the World Association
for the Advancement of Veterinary Parasitology (WAAVP)
Meeting in 2009 [52], and a full manuscript is in prepara-
tion. FECRTs were performed on 196 horses from farms
practicing selective therapy. Efficacy against P. equorum
was evaluated on 79 of these horses and was found to be
96% across all farms. Strongyle efficacy was 100% on all
the farms. Egg reappearance periods (ERP) were investi-
gated on nine of these farms with a total of 96 horses.
Weekly FECRTs found ERPs to be at least six weeks on all
the farms. In conclusion, this study illustrated no signs of
ivermectin resistance in strongyle parasites, and an overall
96 % efficacy against P. equorum as well. This is in contrast
to a German study, where a strongyle ERP of five weeks
was reported [12]. Ivermectin resistance in P. equorum has
been documented in several European countries [9,12,14,
16] including Denmark [11]. The present study suggests
that ivermectin most likely still remains efficacious
against  P. equorum on a majority of farms, even in
countries where resistance has previously been reported
on a case-basis.
Potential adverse effects of selective therapy
Very little evidence exists evaluating the long-term effects
of anthelmintic treatment programs using selective
therapy, and most statements made at this point will be
speculative. However, one focus in Denmark is the
prevalence of S. vulgaris, and it has been hypothesized
that the big proportion of horses receiving little or no
treatments due to their constantly low egg counts would
allow this parasite to become more prevalent. This would
be of concern, since S. vulgaris is known to be very
pathogenic. Because of this, we included individual larval
cultures in the pyrantel study mentioned above [50] to
account for the prevalence of this parasite. As such, 1644
individual larval cultures were performed and 5% were
found positive. On the farm level, 31 of the 64 farms had
at least one horse positive for this parasite.
Historically, S. vulgaris was reported to be virtually 100 %
prevalent in individual horses [52-57], so in this context
a prevalence of 5% cannot be claimed dramatic. However,
it becomes relevant to investigate if Denmark has
significantly higher levels of S. vulgaris than countries
without prescription-only conditions. A Swedish abattoir
survey performed in the mid 1990s reported 6.1% of 461
horses with lesions in the cranial mesenteric artery, and
subsequent larval cultures from these horses yielded a
S. vulgaris prevalence of 3.6 % [58]. At the time of this
study, anthelmintics were still available over-the-counter
in Sweden, but yet the S. vulgaris prevalence was at the
same level as in the Danish 2008 study. In addition, a
questionnaire survey performed in 2003, revealed that
Swedish horse owners treated without performing egg
counts and with the annual number of treatments per
horse averaging 3.2 [46]. This is similar to Danish treat-
ment conditions prior to 1999 [22]. Limited information
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1999. One study performed in 1996 reported 11 of 56
Danish farms positive, but larval cultures were done by
pooling feces from several horses in each culture [49].
Such composite cultures are most likely to underestimate
the prevalence, since the few large strongyle larvae will be
overwhelmed by the many cyathostomin larvae from
negative horses in each culture. Thus, a direct comparison
with the present study cannot be made. Hence, it remains
unresolved whether Danish treatment restrictions have
led to higher S. vulgaris prevalences, and presently no
conclusions can be made either way.
Discussion
Prescription-only restrictions represent one way of
ensuring veterinary involvement in the anthelmintic
strategies in livestock animals. The Danish experiences
strongly suggest that veterinarians have taken a lead role
in equine establishments, and as such the legislation can
be determined to be successful. But several new
challenges have arisen from this, and there is a strong
need for scientific studies providing information needed
to meet these challenges.
In a system, where treatments are performed on a pres-
cription basis, high demands are made to the diagnostic
tools available. Although the same basic coprological
techniques have been used for the past 100 years, there is
very little knowledge about their performance as equine
diagnostics. A number of publications report com-
parisons of various egg count techniques and focus on
detection limits, accuracy and repeatability [59,60-62],
but no studies have been published reporting analytical
sensitivities and specificities of these techniques. For
diagnostic tests being used routinely in clinical practice,
this is highly needed. In addition, fecal egg counts are
often claimed to suffer from poor correlations with
actual worm burdens and a couple of studies report raw
data suggesting this [63,64], but so far no statistical
evaluations of this relationship have been published. In
addition, it becomes increasingly important to account
for parasite burdens on a species level to better the
clinical implication of any given egg count. Larval
cultures are widely used in Denmark, but like egg count
techniques this technique has never been validated as a
diagnostic tool for equine usage. Thus, we don’t have any
information on the reliability of, for example a S. vulgaris
negative culture. It is perceived that the diagnostic
sensitivity is low, since even cultures with S. vulgaris
larvae are largely dominated by cyathostomins. In
addition, the larval culture method is time-consuming
and laborious. Recent advances with molecular
techniques detecting DNA from S. vulgaris have shown
promise [65,66], but have not yet been made available
for equine practitioners.
The large degree of veterinary involvement also makes huge
demands on knowledge in the veterinary community.
Horse owners often complain over conflicting messages
when they ask different veterinarians for parasite advice,
and there is a constant need for continuing education.
Thus, there is a considerable gap in knowledge that needs
to be filled. In Denmark, equine parasitology has been an
integrated part of the course package for continuing
education for veterinary practitioners over the past decade,
and most certainly this has improved the general level of
knowledge. Parasite control can be regarded a specialty area
within veterinary medicine, and some Danish practices
have specialized themselves in running fecal samples and
providing advice on performing parasite control as their
primary source of income. This trend could potentially
become common in other countries as well.
Although anthelmintic strategies based on the selective
therapy principle have been recommended for two
decades, no long term evaluations have been performed.
Thus, we lack knowledge on the following areas: 1) Rate of
development of anthelmintic resistance, 2) Prevalence
levels of specific parasite species of particular pathogenic
potential, 3) Risk of parasitic disease, and 4) Other objec-
tive parameters such as body condition/weight gain.
Studies evaluating these parameters are highly needed for
equine parasite control to move forward. As mentioned
above, the selective therapy approach is one way to employ
a more sustainable treatment principle. However, other
methods may be developed in the future. One such
example is the concept of mosaic treatments, which has
been developed for insecticides [67]. The principle is to
apply treatments with different pharmacological products
to different parts of the host population. Theoretically, this
should ensure adequate parasite refugia to each drug type.
As such, mosaic treatments represent an alternative to the
traditional drug rotations or combination treatments, and
experimental evidence evaluating this approach in horses
should be highly welcomed.
Conclusions
Prescription-only restrictions have led to increased veteri-
nary involvement, and reduced anthelmintic treatment
intensity in Denmark. How these treatment conditions
affect levels of anthelmintic resistance and the overall
health of horses on the longer term remains unknown.
Emphasis is being put on the performance of diagnostic
tools, and more data is needed to fully validate the
techniques used presently.
Competing interests
The author declares that they have no competing interests.
Acknowledgements
The author is grateful to Dr.Patrick Meeus,Pfizer inc.for valuable input on
mosaic treatments,and Dr.Susanne N.Olsen,University of Copenhagen for
critically reviewing the manuscript.
Parasites & Vectors 2009, 2(Suppl 2):S7 http://www.parasitesandvectors.com/content/2/S2/S7
Page 5 of 7
(page number not for citation puroposes)This article is published as part of Parasites & VectorsVolume 2 Supplement
2, 2009. This supplement includes the Proceedings of the “Workshop on
equine cyathostomins, the most important parasitic helminth of horses:
epidemiology, clinical significance, drug resistance and control” that was
held at the University of Teramo, Italy on 20th May, 2009. Additional
articles cover other equine nematode parasites, new developments in
diagnostic techniques and proposals for more effective sustainable
control programmes.The full contents of this supplement are available
online at http://www.parasitesandvectors.com/supplements/2/S2.
Publication of this supplement has been sponsored by Fort Dodge Animal
Health.
References
1. Drudge JH, Lyons ET: Control of internal parasites of horses. J
Am Vet Med Assoc 1966, 148:378-383.
2. Poynter D, Hughes DL: Phenothiazine and piperazine, an
efficient anthelmintic mixture for horses. Vet Rec 1958, 70:
1183-1188.
3. Gibson TE: Some experiences with small daily doses of
phenothiazine as a means of control of strongylid worms in
the horse. Vet Rec 1960, 72:37-41.
4. Drudge JH,Elam G:Preliminary observations on the resistance
of horse strongyles to phenothiazine.J Parasitol 1961,47: 38-39.
5. Kelly J, Webster J, Griffin D, Whitlock H, Martin I, Gunawan M:
Resistance to benzimidazole anthelmintics in equine
strongyles. 1. Frequency, geographical distribution and
relationship between occurrence, animal husbandry
procedures and anthelmintic usage. Aust Vet J 1981, 57:163-171.
6. Uhlinger CA,Kristula M:Effects of alternation of drug classes on
the development of oxibendazole resistance in a herd of
horses. J Am Vet Med Assoc 1992, 201:51-55.
7. Kaplan RM: Anthelmintic resistance in nematodes of horses.
Vet Res 2002, 33:491-507.
8. Kaplan RM: Drug resistance in nematodes of veterinary
importance: a status report. Trends Parasitol 2004, 20:477-481.
9. Boersema JH, Eysker M, Nas JWM: Apparent resistance of
Parascaris equorum to macrocylic lactones. Vet Rec 2002, 150:
279-281.
10. Hearn FPD, Peregrine AS: Identification of foals infected with
Parascaris equorum apparently resistant to ivermectin. J Am Vet
Med Assoc 2003, 223:482-485.
11. Schougaard H, Nielsen MK: Apparent ivermectin resistance of
Parascaris equorum in Danish foals. Vet Rec 2007, 160:439-440.
12. Samson-Himmelstjerna G von, Fritzen B, Demeler J, Schurmann S,
Rohn K,Schnieder T,Epe C:Cases of reduced cyathostomin egg-
reappearance period and failure of Parascaris equorum egg
count reduction following ivermectin treatment as well as
survey on pyrantel efficacy on German horse farms. Vety
Parasitol 2007, 144:74-80.
13. Craig TM, Diamond PL, Ferwerda NS, Thompson JA: Evidence of
ivermectin resistance by Parascaris equorum on a Texas horse
farm. J Equine Vet Sci 2007, 27:67-71.
14. Lindgren K,Ljungvall Ö,Nilsson O,Ljungström BL,Lindahl C,Höglund
J: Parascaris equorum in foals and in their environment on a
Swedish stud farm, with notes on treatment failure of
ivermectin. Vet Parasitol 2008, 151:337-343.
15. Slocombe JOD, de Gannes RVG, Lake MC: Macrocyclic lactone-
resistant Parascaris equorum on stud farms in Canada and
effectiveness of fenbendazole and pyrantel pamoate. Vet
Parasitol 2007, 145:371-376.
16. Veronesi F, Moretta I, Moretti A, Fioretti DP, Genchi C: Field
effectiveness of pyrantel and failure of Parascaris equorum egg
count reduction following ivermectin treatment in Italian
horse farms. Vet Parasitol 2009, 161:138-141.
17. Kaplan RM,Reinemeyer CR,Slocombe O,Murray MJ:Confirmation
of ivermectin resistance in a purportedly resistant Canadian
isolate of Parascaris equorum in foals. In  Proceedings American
Association of Veterinary Parasitologists 51st Annual Meeting: July 15-18,
2006; Honolulu, 69-70.
18. Lyons ET,Tolliver SC, Ionita M, Lewellen A, Collins SS: Field studies
indicating reduced activity of ivermectin on small strongyles
in horses on a farm in Central Kentucky.Parasitol Res 2008,103:
209-215.
19. Molento MB, Antunes J, Bentes RN, Coles GC: Anthelmintic
resistant nematodes in Brazilian horses. Vet Rec 2008 162:384-
385.
20. Lyons E,Tolliver S,Collins S:Probable reason why small strongyle
EPG counts are returning “early” after ivermectin
treatment of horses on a farm in Central Kentucky. Parasitol
Res 2009, 104:569-574.
21. O’Meara B, Mulcahy G:A survey of helminth control practices
in equine establishments in Ireland. Vet Parasitol 2002, 109:101-
110.
22. Lendal S, Larsen MM, Bjørn H, Craven J, Chriel M, Olsen SN: A
questionnaire survey on nematode control practices on
horse farms in Denmark and the existence of risk factors for
the development of anthelmintic resistance. Vet Parasitol 1998,
78:49-63.
23. Wyk JA van: Refugia - overlooked as perhaps the most potent
factor concerning the development of anthelmintic
resistance. Onderstepoort J Vet 2001, 68:55-67.
24. Wyk JA van, Hoste H, Kaplan RM, Besier RB: Targeted selective
treatment for worm management – how do we sell rational
programs to farmers? Vet Parasitol 2006, 139:336-346.
25. Eysker M, Doorn DCK van, Lems SN, Weteling A, Ploeger HW:
Frequent de-worming in horses; the advantage often more
damage than good. Tijdschr Diergeneesk 2006, 131:524-530 (In
Dutch).
26. Crofton HD: Quantitative approach to parasitism. Parasitology
1971, 62:179-193.
27. Sréter T, Molnár V, Kassai T: The distribution of nematode egg
counts and larval counts in grazing sheep and their
implications for parasite control. Int J Parasitol 1994,24:103-108.
28. Galvani AP: Immunity, antigenic heterogeneity, and
aggregation of helminth parasites. J Parasitol 2003, 89:232-241.
29. Malan FS,Wyk JA van,Wessels CD:Clinical evaluation of anaemia
in sheep: early trials. Onderstepoort J Vet 2001, 61:165-174.
30. Wyk JA van, Bath GF: The FAMACHA© system for managing
haemonchosis in sheep and goats by clinically identifying
individual animals for treatment. Vet Res 2002, 33:509-529.
31. Kaplan RM, Burke JM,Terill TH, Miller JE, Getz WR, Mobini S,Valencia
E,Williams MJ,Williamson LH, Larsen M,Vatta AF: Validation of the
FAMACHA© eye color chart for detecting clinical anaemia in
sheep and goats on farms in southern United States. Vet
Parasitol 2004, 123:105-120.
32. Ejlertsen M,Githigia SM,Otieno RO,Thamsborg SM:Accuracy of an
anaemia scoring chart applied on goats in sub-humid Kenya
and its potential for control of Haemonchus contortus
infections. Vet Parasitol 2006, 141:291-301.
33. Burke JM,Kaplan RM,Miller JE,Terrill TH,Getz WR,Mobini S,Valencia
E, Williams MJ, Williamson LH, Vatta AF: Accuracy of the
FAMACHA system for on-farm use by sheep and goat
producers in the southeastern United States. Vet Parasitol 2007,
147:89-95.
34. Koopmann R,Holst C,Epe C:Experiences with the FAMACHA©
eye-colour-chart for identifying sheep and goats for targeted
anthelmintic treatment. Berl Munch Tierartzl 2006, 119:436- 442
(In German).
35. Duncan JL, Love S: Preliminary observations on an alternative
strategy for the control of horse strongyles. Equine Vet J 1991,
23:226-228.
36. Gomez HH, Georgi JR: Equine helminth infections: control by
selective chemotherapy. Equine Vet J 1991, 23:198-200.
37. Krecek RC,Guthrie AJ,Nieuwenhuizen Lv,Booth LM,Nieuwenhuizen
LCv: A comparison between the effects of conventional and
selective antiparasitic treatments on nematode parasites of
horses from two management schemes. J S Afr Vet Assoc 1994,
65:97-100.
38. Matthee S, McGeoch MA: Helminths in horses: use of selective
treatment for the control of strongyles.J S Afr Vet Assoc 2004,75:
129-136.
39. Nielsen MK, Haaning N, Olsen SN: Strongyle egg shedding
consistency in horses on farms using selective therapy in
Denmark. Vet Parasitol 2006, 135:333-335.
40. Döpfer D, Kerssens CM, Meijer YG, Boersema JH, Eysker M:
Shedding consistency of strongyle-type eggs in Dutch
boarding horses. Vet Parasitol 2004, 124: 249-258.
Parasites & Vectors 2009, 2(Suppl 2):S7 http://www.parasitesandvectors.com/content/2/S2/S7
Page 6 of 7
(page number not for citation puroposes)41. Pascoe RJ, Wilson TJ, Coles GC: Nematode control in eventer
horses. Vet Rec 1999, 145:200-201.
42. Biggin TA, Bristol A, Coles GC: Parasite control in horses of
members of pony clubs. Equine Vet Educ 1999, 11:318-321.
43. Lloyd S, Smith J, Connan RM, Hatcher MA, Hedges TR, Humphrey DJ,
Jones AC: Parasite control methods used by horse owners:
factors predisposing to the development of anthelmintic
resistance in nematodes. Vet Rec 2000, 146:487-492.
44. Earle CG, Kington HA, Coles GC: Helminth control used by
trainers of thoroughbreds in England. Vet Rec 2002, 150:405-
408.
45. Matthee S,Dreyer FH,Hoffmann WA,Niekirk FEv:An introductory
survey of helminth control practices in South Africa and
anthelmintic resistance on Thoroughbred stud farms in the
Western Cape Province. J S Afr Vet Assoc 2002, 73:195-200.
46. Lind EO, Rautalinko E, Uggla A,Waller PJ, Morrison DA, Höglund J:
Parasite control practices on Swedish horse farms. Acta Vet
Scand 2007, 49:25-34.
47. NAHMS, equine 1998, Part III: Management and Health of
Horses, 1998. National Animal Health Monitoring System, USDA:
APHIS:VS, 1998, Fort Collins.
48. Nielsen MK,Monrad J,Olsen SN:Prescription-only anthelmintics -
A questionnaire survey on strategies for surveillance and
control of equine strongyles in Denmark.Vet Parasitol 2006,135:
47-55.
49. Craven J, Bjørn H, Henriksen SA, Nansen P, Larsen M, Lendal S:
Survey of anthelmintic resistance on Danish horse farms,
using 5 different methods of calculating faecal egg count
reduction. Equine Vet J 1998, 30:289-293.
50. Nielsen MK, Petersen SL,Vidyashankar AN, Hanlon B, Kaplan RM.:
Prevalence of Strongylus vulgaris and pyrantel resistant
cyathostomins on Danish horse farms using selective
therapy. In Proceedings for the World Association for the Advancement of
Veterinary Parasitology (WAAVP),August 8-19, 2009, Calgary, Canada.
51. Lind EO, Kuzmina T, Uggla A,Waller PJ, Höglund J: A Field Study on
the Effect of Some Anthelmintics on Cyathostomins of
Horses in Sweden. Vet Res Comm 2007, 31:53-56.
52. Larsen ML, Ritz C, Petersen SL, Nielsen MK: Determination of
ivermectin strongyle efficacy and egg reappearance period
(ERP) on Danish horse farms. In  the World Association for the
Advancement of Veterinary Parasitology (WAAVP), August 8-13, 2009,
Calgary, Canada.
53. Bollinger O: Die kolik der Pferde und das Wurmaneurysma
der Eingeweidearterien. Münchener Sitzungsberichte Königliche
Bayerischen Akademie der Wissenschaften, Mathematisch-naturwissen-
schaftliche Abteilung 1 1870, 539-544 (In German).
54. Robertson D: Intestinal parasites of Shetland Ponies in the
North of Scotland. Vet Rec 1939, 51:779-781.
55. Slocombe JOD, McCraw BM: Gastrointestinal nematodes in
horses in Ontario. Can Vet J 1973, 14:101-105.
56. Tolliver SC,Lyons ET,Drudge JH:Prevalence of internal parasites
in horses in critical tests of activity of parasiticides over a 28-
year period (1956-1983) in Kentucky. Vet Parasitol 1987, 23:273-
284.
57. Lyons ET, Drudge JH, Tolliver SC: Prevalence of some internal
parasites found (1971-1989) in horses born on a farm in
central Kentucky. J Equine Vet Sci 1990, 10:99-107.
57. Lyons ET,Drudge JH,Tolliver SC:Review of prevalence surveys of
internal parasites recovered (1951-1990) from horses at
necropsy in Kentucky. J Equine Vet Sci 1992, 12:9-16.
58. Höglund J,Ljungstrom BL,Nilsson O,Lundquist H,Osterman E,Uggla
A:Occurrence of Gasterophilus intestinalis and some parasitic
nematodes of horses in Sweden. Acta Vet Scand 1997,38:157-165.
59. Egwang TG, Slocombe, JOD: Evaluation of the Cornell-
Wisconsin centrifugal flotation technique for recovering
trichostrongylid eggs from bovine feces. Can J Comp Med 1982,
46:133-137.
60. Uhlinger C: Uses of Fecal Egg Count Data in Equine Practice.
Comp Cont Educ Vet Pract 1993, 15:742–749.
61. Cringoli G,Rinaldi L,Veneziano V,Capelli G,Scala A:The influence of
flotation solution, sample dilution and the choice of
McMaster slide area (volume) on the reliability of the
McMaster technique in estimating the faecal egg counts of
gastrointestinal strongyles and Dicrocoelium dendriticum in
sheep. Vet Parasitol 2004, 123:121-131.
62. Presland SL, Morgan ER, Coles GC: Counting nematode eggs in
equine faecal samples. Vet Rec 2005, 156:208-210.
63. Duncan JL: Field studies on the epidemiology of mixed
strongyle infections in the horse. Vet Rec 1974, 94:337-345.
64. Chapman MR, French DD; Klei, TR: Prevalence of strongyle
nematodes in naturally infected ponies of different ages and
during different seasons of the year in Louisiana. J Parasitol
2003, 89:309-314
65. Traversa D, Iorio R, Klei TR, Kharchenko VA, Gawor J,
Otranto D, Sparagano OAE: New Method for Simultaneous
Species-Specific Identification of Equine Strongyles
(Nematoda, Strongylida) by Reverse Line Blot
Hybridization. J Clin Microbiol 2007, 45:2937-2942.
66. Nielsen MK, Peterson DS, Monrad J,Thamsborg ST, Olsen SN Kaplan
RM: Detection and semi-quantification of Strongylus vulgaris
DNA in equine faeces by real-time PCR. Int J Parasitol 2008, 38:
443–453.
67. McKenzie CL, Byford RL: Continuous, Alternating, and Mixed
Insecticides Affect Development of Resistance in the Horn
Fly (Diptera: Muscidae). J Econ Entomol 1993, 86:1040-1048.
Parasites & Vectors 2009, 2(Suppl 2):S7 http://www.parasitesandvectors.com/content/2/S2/S7
Page 7 of 7
(page number not for citation puroposes)